Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.

Macular degeneration is the most common cause of age-related vision loss in older adults. In a healthy eye, light travels through the pupil and hits the retina, the inner back layer of your eye.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

This can help doctors detect macular degeneration and distinguish between wet and dry types. Macular degeneration is the breakdown of the central part of your retina. It’s a feature of age ...

Ocugen said the Food and Drug Administration lifted a clinical hold on its OCU200 investigational treatment for diabetic macular edema, paving the way for Phase 1 trials.

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust ...

Certain arm positions commonly used for blood pressure checks may lead to inaccurate results. Here’s the right way to do it ...

• Compared to human experts, artificial intelligence (AI)-based tests may be comparably accurate at detecting the exudative (or wet) form of age-related macular degeneration (eAMD). • There were no ...

This year the Nobel Physics Prize has gone to AI and machine learning experts instead of a physicist. Take a look.

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...